Dual Infection (HCV/TB)

Treatment-Related Liver Toxicity Worse in HCV Positive Patients

Published in AIDS Weekly, August 24th, 1998

Hepatitis C virus infection appears to play an important role in the development of treatment-induced liver problems in tuberculosis patients.

"Considering the potential large number of patients infected with both TB and hepatitis C virus (HCV) who may need (antituberculosis therapy), this association may have important implications," Jaime R. Ungo and colleagues wrote ("Antituberculosis Drug-Induced Hepatotoxicity, The Role of Hepatitis C Virus and HIV," American Journal of Respiratory and Critical Care Medicine, July, 1998;157:1871-1876).

"Clinicians treating patients at high risk for HIV and/or HCV with anti-TB agents may need to consider...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1998-08-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry